Medicaid and the HIV/AIDS epidemic in the United States.
Graydon, T Randolph
Date of Pub
This article explores the impact on Medicaid costs of new AIDS treatments and other technology advances. Available data on
total projected Medicaid expenditures and actual expenditures for antiretroviral drugs are presented. The article further
addresses Medicaid State agencies' efforts to assure that Medicaid-eligible persons with AIDS receive quality care, and reviews
recent studies on utilization of services among persons with HIV disease.
Acquired Immunodeficiency Syndrome/economics : Health Expenditures : HIV Infections/economics : Medicaid : Health Services/utilization
: Quality of Health Care : Technology, Medical/economics : United States : United States Health Care Financing Administration